Instalab
logoInstalab

Hazelnut (Cor a 8) IgE

Blood Test
See whether your body recognizes the hazelnut protein tied to systemic reactions, beyond what a standard hazelnut allergy test shows.
4.9 (2,257 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Hazelnut (Cor a 8) IgE test?

This test is most useful if any of these apply to you.

Reacted to Hazelnut Before
This test can show whether your reaction is the more severe LTP-driven type rather than the milder pollen-related form.
Reacting to Multiple Plant Foods
If peach, peanut, apple, or other plant foods trigger you, this result helps identify whether LTP syndrome is the underlying pattern.
Had Unexplained Anaphylaxis
When systemic reactions happen without a clear trigger, this component can flag whether stable food proteins like LTPs are involved.
From a Mediterranean Background
LTP-driven hazelnut allergy is more common in southern Europe, making this component particularly relevant if you have roots in those regions.

About Hazelnut (Cor a 8) IgE

If you have ever reacted to hazelnut, or noticed your reactions getting worse over time, the question that matters most is not just whether you are sensitized, but which part of the hazelnut your immune system has locked onto. That distinction can mean the difference between mild mouth itching and a systemic reaction with hives, breathing trouble, or anaphylaxis.

This test measures IgE (immunoglobulin E, the antibody class your body makes during allergic responses) against Cor a 8, a specific hazelnut protein in a family called non-specific lipid transfer proteins, or LTPs. A positive result points to one particular slice of hazelnut allergy biology, one that behaves differently from the more common pollen-related hazelnut sensitivity.

What Cor a 8 Actually Is

Cor a 8 is a small, structurally stable hazelnut protein that resists heat and digestion. That stability matters: unlike pollen-related hazelnut proteins, which often break down in the stomach and cause mild mouth-only symptoms, Cor a 8 can survive into the bloodstream and trigger reactions in distant parts of the body.

When your immune system is sensitized to Cor a 8, B cells (the immune cells that make antibodies) produce IgE antibodies that recognize this protein. Those antibodies coat mast cells (immune cells that release histamine and related chemicals) in your skin, gut, and airways. The next time you eat hazelnut, the protein binds those antibodies and tells the cells to release the chemicals that cause allergic symptoms. The blood test detects the antibodies themselves, not the reaction.

Why This Component Matters for Reaction Severity

Cor a 8 sensitization is linked to a more serious clinical picture. In a small Dutch study of 26 children from a birch-pollen-heavy area who underwent a double-blind hazelnut food challenge, every child with objective systemic reactions had detectable Cor a 8 IgE, and the marker remained an independent risk factor for objective symptoms on multivariate analysis. The sample size was small, but the signal was consistent. In Italian children, higher Cor a 8 levels increased the odds of failing an oral food challenge.

A clinically important nuance: in an Italian adult study, patients monosensitized to Cor a 8 (without concurrent Cor a 1 sensitization) had significantly more frequent and more severe systemic reactions than patients who were co-sensitized to both Cor a 1 and Cor a 8. In other words, having birch-pollen-related Cor a 1 sensitization alongside Cor a 8 appears to soften the reaction profile, while Cor a 8 alone marks the highest-risk pattern.

In Mediterranean countries and other regions where hazelnut LTP allergy is common, Cor a 8 is often the main driver of hazelnut reactions, clustering with sensitization to LTPs in peanut, peach, and other plant foods. Many people positive for Cor a 8 are not just reacting to hazelnut, they have a broader LTP syndrome that can involve multiple foods.

How Cor a 8 Differs From a Standard Hazelnut IgE

A standard hazelnut IgE test uses whole hazelnut extract, which is a mix of every allergen in the nut. It is very sensitive but not specific: many people test positive without ever reacting clinically, often because they are sensitized to harmless birch-pollen-related hazelnut proteins. Component testing breaks the result apart so you know which protein your immune system is responding to.

Cor a 8 is the LTP marker in that breakdown. Two other hazelnut components, Cor a 9 and Cor a 14, are storage proteins more closely tied to severe pediatric hazelnut allergy. A complete picture often requires looking at all three together.

Risk of Systemic Reactions

A positive Cor a 8 result, especially in someone with a history of hazelnut symptoms, supports the diagnosis of LTP-driven hazelnut allergy. This phenotype is associated with reactions beyond the mouth: hives, swelling, breathing constriction, and anaphylaxis. The risk is more pronounced in Mediterranean populations, where Cor a 8 is a major driver of hazelnut allergy and clusters with sensitization to other LTP-containing foods.

Across large US and European datasets, Cor a 8 sensitization is present in a meaningful minority of hazelnut-sensitized people, fairly constant with age. In a systematic review of LTP testing, Cor a 8 IgE showed modest sensitivity and moderate to high specificity for hazelnut allergy. In plain terms, a positive result is meaningful and worth taking seriously, but a negative result does not rule out hazelnut allergy.

Why Low Cor a 8 Does Not Mean You Are Safe

Many hazelnut-allergic children are negative for Cor a 8 but positive for the storage proteins Cor a 9 or Cor a 14. In pediatric reviews, Cor a 8 shows low sensitivity for clinical hazelnut allergy, much lower than the storage protein markers. In infants with eczema, early hazelnut sensitization often targets Cor a 9 without any detectable Cor a 8.

Apparent contradiction worth resolving: Cor a 8 is strongly linked to severe reactions, yet its sensitivity is low. The two facts are consistent. Cor a 8 is a phenotype marker, not a screening test. When it is positive, it identifies a specific, higher-risk pattern of hazelnut allergy. When it is negative, you may still have hazelnut allergy through a completely different protein, which is why Cor a 9 and Cor a 14 are usually tested at the same time.

Connection to Other LTP Allergies

LTPs in different plants share enough structural similarity that IgE made against one can recognize others. People with Cor a 8 sensitization frequently have IgE to peanut Ara h 9, peach Pru p 3, and walnut LTPs. This co-sensitization pattern is what allergists call LTP syndrome: a single immune profile that affects how you eat across many food categories, not just hazelnut.

For LTP allergy specifically, sensitization to peanut and hazelnut LTPs supports the diagnosis, alongside the more central marker, the Pru p 3 to total IgE ratio. If Cor a 8 is positive, it is worth investigating whether your immune system is reacting to LTPs across multiple foods.

Tracking Your Result Over Time

A single Cor a 8 IgE result is a snapshot. Sensitization patterns can shift as you age, as exposures change, and as the underlying immune response evolves. In sensitization profiles tracked across the US, age changed which hazelnut components dominated, with Cor a 9 and Cor a 14 predominant in young children shifting toward Cor a 1 predominance in adults, which means the picture at 5 is not the picture at 25.

If your initial result is positive, retesting at six to twelve months and then annually is a reasonable expert-opinion approach, though it is not driven by formal guidelines. Rising levels alongside ongoing exposure suggest the allergy is consolidating. Falling levels over years in someone successfully avoiding hazelnut can signal that the immune system is losing interest, though this is not the same as outgrowing the allergy. Trends matter more than single values.

When Results Can Be Misleading

A few situations can distort a single Cor a 8 reading:

  • Variant assay platforms: different lab methods can produce different numeric values for the same sample, so compare results from the same lab when tracking trends.
  • Recent allergic reactions or high total IgE: a very high total IgE from eczema or other allergies can affect how component results are interpreted, though component-to-total IgE ratios do not improve hazelnut allergy diagnosis specifically.
  • Cross-reactivity with other LTPs: a positive Cor a 8 may partly reflect sensitization to LTPs in peach, peanut, or mugwort pollen rather than independent hazelnut sensitization.
  • Acid-suppressing medications: in a human study, about 15% of 152 gastroenterology patients developed new food-specific IgE during a three-month course of antiulcer drugs, with a roughly tenfold relative risk compared with controls, and some developed clinical food allergy. This is a genuine change in your biology, not a measurement artifact, but it can complicate interpretation if you started these drugs recently.

What to Do With an Unexpected Result

If Cor a 8 IgE is positive and you have a history of hazelnut reactions, the next step is usually a workup with an allergist, ideally one familiar with component-resolved diagnostics. Companion tests typically include Cor a 9 and Cor a 14 to characterize the full hazelnut profile, plus peanut Ara h 9 and peach Pru p 3 if LTP syndrome is suspected. A skin prick test or oral food challenge may be needed to confirm clinical reactivity, since blood tests reflect sensitization, not certainty of a reaction.

If Cor a 8 is positive but you have never knowingly reacted to hazelnut, this is meaningful information but not a diagnosis. Sensitization without symptoms is common. The result raises your prior probability of LTP-driven reactions to multiple foods and is worth discussing with an allergist before deliberately eating hazelnut to test the waters. If you have had unexplained reactions to foods that share LTPs, this result can help connect the dots.

For anyone with confirmed hazelnut allergy and a positive Cor a 8, the practical implications include strict avoidance, carrying epinephrine, and discussing whether hazelnut oral immunotherapy or sublingual immunotherapy is appropriate. These are the only interventions shown to change the underlying allergic biology, though most published trials focus on outcomes other than Cor a 8 levels specifically.

What Moves This Biomarker

Evidence-backed interventions that affect your Hazelnut (Cor a 8) IgE level

↓ Decrease
Sublingual immunotherapy with standardized hazelnut extract
Hazelnut sublingual immunotherapy raises the dose of hazelnut you can tolerate without reacting, which is the clinical outcome that matters most for someone with hazelnut allergy. In a randomized, double-blind, placebo-controlled trial of 23 adults, sublingual hazelnut extract increased the tolerated dose of hazelnut several-fold, while also raising protective IgG4 antibodies and the regulatory signaling molecule IL-10. The trial did not measure Cor a 8 IgE directly, so a decrease in Cor a 8 IgE specifically is inferred from the broader shift in allergic immune response, not directly demonstrated.
MedicationModest Evidence
↓ Decrease
Hazelnut oral immunotherapy
Hazelnut oral immunotherapy raises your tolerance threshold by gradually exposing your immune system to increasing doses of hazelnut protein. In a cohort of 88 children, daily hazelnut oral immunotherapy over about 12 months achieved desensitization in roughly half on intention-to-treat analysis and about three-quarters of those who completed the protocol. The challenge threshold rose substantially over the same period. Storage protein IgE (Cor a 14 and Cor a 9) fell over the same period, suggesting the underlying allergic biology shifted, but direct Cor a 8 measurements were not reported, so the direction for Cor a 8 specifically is inferred rather than measured.
MedicationModest Evidence
↑ Increase
Omalizumab anti-IgE therapy
Omalizumab is an anti-IgE biologic that binds free IgE and blocks it from attaching to mast cells, reducing your reactivity to whatever you are allergic to, including hazelnut. In the OUtMATCH randomized trial, a meaningful majority of treated participants reached tolerance to a clinically significant dose of multiple food allergens, including hazelnut, compared with a small fraction on placebo. The drug changes the functional consequences of having allergen-specific IgE in your blood rather than reducing production of Cor a 8 IgE itself, and effects on Cor a 8 IgE levels specifically have not been published.
MedicationModest Evidence
↑ Increase
Long-term proton pump inhibitor or H2 blocker therapy
Acid-suppressing drugs can cause new hazelnut sensitization by allowing intact hazelnut proteins to reach the gut immune system instead of being broken down by stomach acid. In a study of 152 gastroenterology patients, about 15% developed new food-specific IgE during a 3-month course of antiulcer medication, with a relative risk of roughly 10.5 compared with controls, and some developed clinical allergy confirmed by food challenge. Larger population-level studies have since reinforced the link between acid-suppressive therapy and food allergy risk. If you start one of these drugs and notice new food reactions, this mechanism is worth raising with your doctor.
MedicationModest Evidence

Frequently Asked Questions

References

19 studies
  1. Valcour a, Lidholm J, Borres M, Hamilton RThe Journal of Allergy and Clinical Immunology2019
  2. Bellia C, Sardina DS, Scazzone C, Lio D, Scola L, Uasuf CGInternational Journal of Molecular Sciences2024
  3. Datema M, Zuidmeer-jongejan L, Asero R, Barreales L, Belohlavkova S, De Blay F, Ballmer-weber B, Van Ree RThe Journal of Allergy and Clinical Immunology2015
  4. Flinterman AE, Akkerdaas J, Den Hartog Jager CF, Rigby N, Fernandez-rivas M, Pasmans S, Van Ree RThe Journal of Allergy and Clinical Immunology2008